Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Michael Lowe

Research Assistant - Organelle Biology and High-throughput Screening

Michael graduated with a BSc in Natural Sciences from the University of Bath in 2021. This included a year in industry where he worked at the Alzheimer’s Research UK UCL Drug Discovery Institute in London. Here he was part of the Neuroinflammation team, characterising a range of model systems for their suitability for upcoming screening campaigns and performed assay development over a range of platforms including the InCucyte and Operetta. He then completed an MSc in Neuroscience at King’s College London in 2022. His research project here was to develop a full phenotypic assay workflow using iPSCs from culture to automated analysis which was suitable for hit compound screening.

He is now part of the Organelle Biology team at the ARUK Oxford Drug Discovery Institute where he leads a phenotypic cell-based high-throughput screen assessing calcium flux. To date this project has screened over 100,000 small molecules and he is progressing these hits through the hit-to-lead screening cascade utilising a range of platforms including the FLIPR and Opera Phenix.